EN DE
STOCK COMPARISON

PT Soho Global Health Tbk vs McKesson: Fair Value & Quality

Both stocks run through our valuation models. Here is how PT Soho Global Health Tbk (SOHO) and McKesson (MCK) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: PT Soho Global Health Tbk trades at IDR 1,200 versus a fair value of IDR 970 (-19%), while McKesson trades at $870 versus $819 (-6%).
PT Soho Global Health Tbk
SOHO.JK · IDR · Health Care
-19%
upside to fair value
overvalued
PriceIDR 1,200
Fair ValueIDR 970
Quality70/100
McKesson
MCK · USD · Health Care
-6%
upside to fair value
fairly valued
Price$870
Fair Value$819
Quality66/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

PT Soho Global Health TbkMcKesson
Valuation
23.1×P/E (TTM)21.0×
1.42×P/S (TTM)0.23×
5.90×P/B—
16.8×EV/EBITDA13.9×
—PEG1.57×
—Dividend yield0.4%
—Dividend per share$3.17
Profitability
6%Net margin1%
9%Operating margin2%
23%Return on equity—
9%Return on assets5%
Growth
-1%Revenue growth (YoY)6%
13.9%Avg. growth/yr (3Y)13.4%
11.8%Avg. growth/yr (5Y)11.1%
Balance & size
$2BMarket cap$94B
healthyGrowth qualityhealthy

PT Soho Global Health Tbk leads: 5 to 4 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

PT Soho Global Health Tbkof which business quality 69 · market factors 42 McKessonof which business quality 65 · market factors 63
ProfitabilityMargins and returns on capital today
65
49
Quality GrowthAre margins and returns improving?
45
65
CashflowEarnings quality: real cash, not paper profit
62
47
Fin. StrengthBalance sheet, leverage, solvency risk
84
72
InvestmentDisciplined investing over empire-building
78
76
Low VolatilityCalm price path (market factor)
36
83
MomentumPrice trend over the last 3–12 months (market factor)
36
51
52W MomentumDistance to the 52-week high (market factor)
59
62
Net IssuanceBuybacks instead of dilution
82
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

PT Soho Global Health Tbk

DCF ModelsIDR 1,377
Earnings-BasedIDR 602
Dividend DiscountIDR 453
MultiplesIDR 902
Asset-BasedIDR 136
Growth DCFIDR 1,495
Economic ProfitIDR 569
Growth EarningsIDR 954

17 of 26 models see the stock below the current price.

McKesson

DCF Models$955
Earnings-Based$444
Dividend Discount$57.26
Multiples$848
Growth DCF$922
Economic Profit$497
Growth Earnings$708

13 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

PT Soho Global Health Tbk
Bear IDR 749Fair Value IDR 970Bull IDR 1,241
IDR 1,200 = current price (white tick)
McKesson
Bear $605Fair Value $819Bull $1,034
$870 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

PT Soho Global Health Tbk · Health Care

Quality score70 · Top 25%
Fair value upside-19% · above median

McKesson · Health Care

Quality score66 · Top 25%
Fair value upside-6% · above median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: PT Soho Global Health Tbk trades at IDR 1,200 versus a fair value of IDR 970 (-19%), while McKesson trades at $870 versus $819 (-6%).

PT Soho Global Health Tbk has the higher quality score (70/100).

See the full analysis →
PT Soho Global Health Tbk · McKesson

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to PT Soho Global Health Tbk

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to McKesson

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.